Cargando…
Using Procalcitonin to Guide Antibiotic Therapy
Procalcitonin levels rise in response to systemic inflammation, especially of bacterial origin. Multiple randomized controlled trials have demonstrated that procalcitonin-based algorithms can safely reduce antibiotic use in 2 clinical scenarios. First, in stable, low-risk patients with respiratory i...
Autor principal: | Rhee, Chanu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414114/ https://www.ncbi.nlm.nih.gov/pubmed/28480245 http://dx.doi.org/10.1093/ofid/ofw249 |
Ejemplares similares
-
Impact of Procalcitonin (PCT)-Guided Antibiotic Therapy on Mortality in Critically Ill Patients: A Systematic Review and Meta-Analysis of 18 Randomized Controlled Trials
por: Pepper, Dominique, et al.
Publicado: (2017) -
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy
por: Creamer, Andrew W., et al.
Publicado: (2019) -
Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit
por: Carr, John Alfred
Publicado: (2015) -
Procalcitonin-guided antibiotics in severe sepsis
por: Simon, Peter, et al.
Publicado: (2008) -
Procalcitonin to Guide Antibiotic Therapy for Critically Ill Patients in Korea
por: Park, Seong Yeon
Publicado: (2019)